ViBA

MANF promotes cell fitness and attenuates bortezomib sensitivity in multiple myeloma.

Huang C, Yu WJ, Rao YX · Translational oncology · 2026 · Article

10.1016/j.tranon.2026.103094

Verified evidence

Model evaluation

abb64bdf-ee21-5e4c-b027-c3cef082c13f
Survival and mortality

Prediction source Version of record · PDF page(s) 6

Study 043b454f-73d3-58ea-9059-d8ee44b5d790 · Prediction record (JSON)

Prediction fields

Endpoint
survival_overall__hazard_ratio · PDF page(s) 6
Family
clinical_outcomes · PDF page(s) 6
Measured variable
survival_overall · PDF page(s) 6
Measurement role
clinical_outcome · PDF page(s) 6
Metric
hazard_ratio · PDF page(s) 6
Outcome target
overall_survival · PDF page(s) 6
Population
human_observations · PDF page(s) 3, 6
Prediction target type
future_clinical_outcome · PDF page(s) 6
Result operation
survival_association · PDF page(s) 6
Role
clinical_outcome · PDF page(s) 6
Unit
dimensionless · PDF page(s) 6

Validation Direct comparison · Same source · Sample overlap · Supports · Matched conditions · Statistically significant